tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cyclerion Therapeutics treatment of mitochondrial disease gets orphan status

Cyclerion Therapeutics’ zagociguat was granted FDA orphan designation as a treatment of mitochondrial disease, according to a post to the agency’s website. Reference Link

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on CYCN:

Disclaimer & DisclosureReport an Issue

1